LSL Pharma Group Inc
LSL.V
$0.26
Closing
▼-2.63%
1D
▼-9.76%
YTD
LSL
BBG001V04B49
Check if the stock is halal
Unlock Industry-grade Shariah Compliance for global stocks. See results from 5 major Shariah standards: AAOIFI, S&P, DJIM, FTSE and MSCI.
We provide unparalleled value and service.
Screened by AAOIFI Certified Shariah Advisor & Auditor.
Get started from just $6.99/month
Market cap
$29.81M
Analysts' Rating
-
Price Target (Mean)
0.00
Total Analysts
0
P/E
Operating Margin
2.15%
Beta
Revenue Growth
59.66%
52 week high
$0.38
52 week low
$0.22
Div. Yield
%
EPS Growth
0.00
Company Profile
LSL Pharma Group Inc. is a Canadian integrated pharmaceutical company. The Company is specialized in the development, manufacturing and commercialization of sterile ophthalmic pharmaceuticals, as well as natural health products in solid dosage forms. It specializes in the manufacturing and marketing of natural health products (NHPs). The Company manufactures a range of NHPs in liquid, powder and capsule form, sold under its own brand or under private labels. Its manufacturing activities include blistering, encapsulation, sachet and jar filling. The Company’s subsidiaries include Steri-Med Pharma Inc., LSL Laboratory Inc. and Groupe Immobilier LSL inc.
